Stay Connected With Us
We want to provide information and news that's relevant to you.
Stay ConnectedJul 26, 2011
Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Recombinant Factor VIII Therapy at International Society on Thrombosis and Haemostasis Meeting Read more »April 26, 2011
Announcement: Amunix Signs Research Collaboration with Biogen Idec for Next Generation Long-Lasting Blood Factor Products Read more »April 15, 2011
Announcement: Biogen Idec Hemophilia celebrates World Hemophilia Day Read more »December 6, 2010
Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Lasting Recombinant Factor VIII Fc Fusion Protein Read more »July 12, 2010
Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the World Federation of Hemophilia Congress Read more »July 9, 2010
Biogen Idec and Swedish Orphan Biovitrum Announce Decision to Advance Long-Lasting Hemophilia A Therapy into a Registrational Trial Read more »February 18, 2010
Biogen Idec and Swedish Orphan Biovitrum Update Hemophilia Partnership Agreement Read more »January 25, 2010
Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Acting Hemophilia B Therapy Read more »October 19, 2009
Biogen Idec and Biovitrum Announce Decision to Advance Long-Acting Hemophilia B Therapy into a Registrational Trial Read more »We want to provide information and news that's relevant to you.
Stay Connected